First Header Logo Second Header Logo

Connection

Kylie Kavanagh to Diet

This is a "connection" page, showing publications Kylie Kavanagh has written about Diet.
Connection Strength

0.426
  1. Szalanczy AM, Sherrill C, Fanning KM, Hart B, Caudell D, Davis AW, Whitfield J, Kavanagh K. A Novel TGFß Receptor Inhibitor, IPW-5371, Prevents Diet-induced Hepatic Steatosis and Insulin Resistance in Irradiated Mice. Radiat Res. 2024 Jul 01; 202(1):1-10.
    View in: PubMed
    Score: 0.181
  2. Mitchell EL, Davis AT, Brass K, Dendinger M, Barner R, Gharaibeh R, Fodor AA, Kavanagh K. Reduced Intestinal Motility, Mucosal Barrier Function, and Inflammation in Aged Monkeys. J Nutr Health Aging. 2017; 21(4):354-361.
    View in: PubMed
    Score: 0.108
  3. Voruganti VS, Jorgensen MJ, Kaplan JR, Kavanagh K, Rudel LL, Temel R, Fairbanks LA, Comuzzie AG. Significant genotype by diet (G × D) interaction effects on cardiometabolic responses to a pedigree-wide, dietary challenge in vervet monkeys (Chlorocebus aethiops sabaeus). Am J Primatol. 2013 May; 75(5):491-9.
    View in: PubMed
    Score: 0.082
  4. Cox LA, Chan J, Rao P, Hamid Z, Glenn JP, Jadhav A, Das V, Karere GM, Quillen E, Kavanagh K, Olivier M. Integrated omics analysis reveals sirtuin signaling is central to hepatic response to a high fructose diet. BMC Genomics. 2021 Dec 03; 22(1):870.
    View in: PubMed
    Score: 0.038
  5. Wagner JD, Zhang L, Kavanagh K, Ward GM, Chin JE, Hadcock JR, Auerbach BJ, Harwood HJ. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys. J Pharmacol Exp Ther. 2010 Oct; 335(1):103-13.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.